TNFSF11 and myocardial infarction: Although fibrosis and inflammation were very moderate in the hearts from 13-month-old mdx mice, our results are consistent with those of Slavic et al. (2018) [38], who showed that a 4 week anti-RANKL treatment following the permanent occlusion of coronary artery did not reduce the inflammation from myocardial infarction.